Last night, the JW Marriott luxury brand celebrated the newly opened landmark hotel in the Middle East and second Marquis worldwide – the JW Marriott Marquis Dubai. Featuring an exclusive performance by British singer / songwriter and recording star, Leona Lewis, the “World’s Tallest Hotel” hosted more than 1,200 VIP guests, including international design icon Donna Karan, local singing sensation Salha and the Million Dollar Band, and Dubai television personality DJ Bliss.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54182-jw-marriott-marquis-dubai-opening-night-spotlights-world-s-tallest-hotel
Eighteen years after opening its internationally prominent Center for Fetal Diagnosis and Treatment, The Children’s Hospital of Philadelphia (CHOP) celebrates 1,000 fetal surgeries – highly complex surgical interventions to repair birth defects in the womb. Approximately 4,000 fetal surgeries have been done worldwide, meaning a quarter of them have been performed at CHOP, the largest number of any hospital in the world.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62038-children-s-hospital-of-philadelphia-celebrates-1000-fetal-surgeries
Feed The Children and World Neighbors announced today that as of March 1, 2013 World Neighbors will become a subsidiary of Feed The Children, Inc. The two Oklahoma City based nonprofits will join forces as strategic partners to better serve those in need worldwide.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60079-feed-the-children-and-world-neighbors-unite
Vivanta by Taj – Hotels & Resorts is pleased to announce the latest accolade. Vivanta by Taj – Madikeri, Coorg, has made it to the Conde Nast Traveller US, UK and India’s Hot List 2013. The Conde Nast Traveller Hot list showcases some of the most authentic havens for travelers across the globe. The publication publishes the list every year and the final selection is made from hundreds of suggestions from magazine correspondents worldwide.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61926-vivanta-by-taj-madikeri-coorg-conde-nast-traveller
Official Web Site: http://www.melogia.com Buy On iTunes: https://itunes.apple.com/us/artist/sarantos/id784136489?ign-mpt=uo%3D4 The 3rd music video is now released worldwide. Sarantos now awaits his fans' reactions to this hysterical video. This video shows a glimpse into the sarcastic and playful nature of Sarantos. Of course, anyone following Sarantos on Facebook or Twitter understands by now the true nature of his demeanor.
With tremendous support and positive feedback on his previous music videos 'Not Where I Wanna Be' and 'Nothing To Hide,' Sarantos is thrilled to see what his fans think of the video. This one is quite different.
'Out Of My Mind' is the BRAND NEW single from UK Producer & DJ Paul Rudd which will be released worldwide in October 2012. Already
getting radio airplay in Europe and the UK, this sixth single from Paul
will feature on his forthcoming album 'Sound of London' alongside
previous releases Neon Lights, Control Me, Set Me Free 2012, More
Amore, Egotastic and X-Me. For Bookings & Management - Anthony Burr anthony@burrmedia.co.uk Tel: 07549 935 196 For Pluggers - Mark Loverush mark@power.co.uk Tel: 0208 932 3030 For Press & Publicity - Brad Taylor brad@bigmachinemedia.com Tel: 0207 936 3722
Once again, Hamilton Watch is on the wrist of an action hero when every second counts in the Paramount Pictures film “Jack Ryan: Shadow Recruit.” In the film, the brand presents the Khaki Titanium and the Khaki Flight Timer, two iconic timepieces made with Swiss precision and American spirit. Hamilton has partnered with Paramount Pictures to promote the global theatrical release of the film, which opens worldwide January 2014.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64180-hamilton-watch-returns-to-big-screen-jack-ryan
A new Economist Intelligence Unit (EIU) report titled The Silent Pandemic: Tackling Hepatitis C with Policy Innovation, made possible as a result of an educational grant from Janssen Pharmaceutica NV and published today, highlights the urgent need for countries around the world to develop strategies to tackle head-on the growing social and economic issues associated with Hepatitis C (HCV).
While the total number of infected individuals is unknown due to a lack of available data, the World Health Organization (WHO) estimates that approximately 150 million people globally are currently living with the blood-borne infectious disease, HCV. Of these, up to two thirds will develop chronic liver disease and one in five will develop cirrhosis. HCV is also the leading cause of liver transplantation worldwide and in the US the disease now accounts for more deaths than HIV.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58671-janssen-silent-pandemic-hepatitis-c
kathy ireland Worldwide® will debut at this year's Licensing Expo, Booth# L81. Ireland was the keynote speaker at last year's Expo. Those responsibilities are assumed this year by Gwyneth Paltrow.
According to Fairchild Publications, Kathy Ireland is one of the 50 most influential people in fashion.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62179-kathy-ireland-worldwide-debuts-at-the-licensing-expo-2013
What could distract die-hard fans from the big game? The same thing captivating millions of readers worldwide: the #1 international bestselling Crossfire series by Sylvia Day. Necessary roughness and play-by-play scoring included. Intensely romantic, darkly sensual and completely addictive, the Crossfire series will take you the end zone… and beyond. http://bit.ly/daybooks Share the Big Game! Romance, Comedy, Media
Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65511-issels-integrative-immunotherapy-non-toxic-treatment-lung-cancer
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program called Cdiffense to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection (CDI). Clostridium difficile (C. diff) is a potentially life-threatening, spore-forming bacterium that causes intestinal disease. The risk of C. diff increases with age, antibiotic treatment and time spent in hospitals or nursing homes, where multiple cases can lead to outbreaks. The investigational vaccine is designed to help protect at-risk individuals from C. diff, which is emerging as a leading cause of life-threatening, healthcare-associated infections (HAIs) worldwide.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62652-sanofi-pasteur-initiates-phase-iii-study-of-investigational-vaccine
